Snipping away at hepatitis C
β
Nicholas A. Shackel; David G. Bowen; Geoffrey W. McCaughan
π
Article
π
2010
π
John Wiley and Sons
π
English
β 655 KB
## Chronic infection with hepatitis C virus (HCV) affects 170 million people worldwide and is the leading cause of cirrhosis in North America. Although the recommended treatment for chronic infection involves a 48-week course of peginterferon-alpha-2b (PegIFN-alpha-2b) or-alpha-2a (PegIFN-alpha-2a